185 related articles for article (PubMed ID: 21563192)
1. EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer.
Zhu H; Zhao J; Zhu B; Collazo J; Gal J; Shi P; Liu L; Ström AL; Lu X; McCann RO; Toborek M; Kyprianou N
Prostate; 2012 Jan; 72(1):72-81. PubMed ID: 21563192
[TBL] [Abstract][Full Text] [Related]
2. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S
Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.
Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z
PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283
[TBL] [Abstract][Full Text] [Related]
4. EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study.
Bilgin Doğru E; Dizdar Y; Akşit E; Ural F; Şanlı Ö; Yasasever V
Tumour Biol; 2014 Nov; 35(11):11647-53. PubMed ID: 25139103
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
Bi XC; Liu JM; Zheng XG; Xian ZY; Feng ZW; Lou YX; Zhong WD; Wu CL
Clin Invest Med; 2011 Dec; 34(6):E358. PubMed ID: 22129926
[TBL] [Abstract][Full Text] [Related]
6. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
7. The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
Madigan MC; Kingsley EA; Cozzi PJ; Delprado WJ; Russell PJ; Li Y
Cancer Immunol Immunother; 2008 Sep; 57(9):1367-79. PubMed ID: 18273614
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
9. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer.
Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y
Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo.
Yang X; Zhang P; Ma Q; Kong L; Li Y; Liu B; Lei D
Cancer Biol Ther; 2012 Jan; 13(2):85-91. PubMed ID: 22198615
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
12. Emmprin, released as a microvesicle in epithelioid sarcoma, interacts with fibroblasts.
Aoki M; Koga K; Hamasaki M; Egawa N; Nabeshima K
Int J Oncol; 2017 Jun; 50(6):2229-2235. PubMed ID: 28498412
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats.
Donadio AC; Remedi MM; Susperreguy S; Frede S; Gilardoni MB; Tang Y; Pellizas CG; Yan L
Histochem Cell Biol; 2008 Dec; 130(6):1155-64. PubMed ID: 18769934
[TBL] [Abstract][Full Text] [Related]
14. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
15. EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.
Delyon J; Khayati F; Djaafri I; Podgorniak MP; Sadoux A; Setterblad N; Boutalbi Z; Maouche K; Maskos U; Menashi S; Lebbé C; Mourah S
Exp Dermatol; 2015 Jun; 24(6):443-8. PubMed ID: 25807898
[TBL] [Abstract][Full Text] [Related]
16. Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus.
Qin Z; Dai L; Slomiany MG; Toole BP; Parsons C
Cancer Res; 2010 May; 70(10):3884-9. PubMed ID: 20406987
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN contributes to the in vitro invasion of human salivary adenoid cystic carcinoma cells.
Yang X; Zhang P; Ma Q; Kong L; Li Y; Liu B; Lei D
Oncol Rep; 2012 Apr; 27(4):1123-7. PubMed ID: 22200897
[TBL] [Abstract][Full Text] [Related]
18. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
19. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.
Chen PS; Shih YW; Huang HC; Cheng HW
PLoS One; 2011; 6(5):e20164. PubMed ID: 21629786
[TBL] [Abstract][Full Text] [Related]
20. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle.
Mishra B; Kizaki K; Koshi K; Ushizawa K; Takahashi T; Hosoe M; Sato T; Ito A; Hashizume K
Reprod Biol Endocrinol; 2010 Jun; 8():60. PubMed ID: 20540754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
